NCT01630187View on ClinicalTrials.gov

Comparison of Two Doses of Carbetocin for Prevention of Uterine Atony, During Elective Cesarean Section

PHASE4CompletedINTERVENTIONAL
Enrollment

72

Participants

Timeline

Start Date

April 30, 2012

Primary Completion Date

July 31, 2012

Study Completion Date

July 31, 2012

Conditions
Uterine AtonyPost-partum Hemorrhage
Interventions
DRUG

Carbetocin

Administration of carbetocin 50 mcg , after clamping the umbilical cord

DRUG

Carbetocin

Administration of carbetocin 100 mcg , after clamping the umbilical cord

Trial Locations (1)

G1L 3L5

Hôpital Saint-François-d'Assise (CHUQ), Québec

All Listed Sponsors
lead

Laval University

OTHER

NCT01630187 - Comparison of Two Doses of Carbetocin for Prevention of Uterine Atony, During Elective Cesarean Section | Biotech Hunter | Biotech Hunter